Naoko Takeda
About
In The Last Decade
Naoko Takeda
61 papers receiving 1.4k citations
Hit Papers
Peers
Comparison fields: 5 of 117
- Biomedical Engineering 485
- Molecular Biology 368
- Endocrinology, Diabetes and Metabolism 206
- Surgery 205
- Physiology 177
Countries citing papers authored by Naoko Takeda
This map shows the geographic impact of Naoko Takeda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naoko Takeda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naoko Takeda more than expected).
Fields of papers citing papers by Naoko Takeda
This network shows the impact of papers produced by Naoko Takeda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naoko Takeda. The network helps show where Naoko Takeda may publish in the future.
Co-authorship network of co-authors of Naoko Takeda
This figure shows the co-authorship network connecting the top 25 collaborators of Naoko Takeda. A scholar is included among the top collaborators of Naoko Takeda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Naoko Takeda. Naoko Takeda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 1 | |
| 4 | SGLT2 Inhibition Mediates Protection from Diabetic Kidney Disease by Promoting Ketone Body-Induced mTORC1 Inhibition breakdown → | 267 |
| 5 | 20 | |
| 6 | 7 | |
| 7 | 40 | |
| 8 | 27 | |
| 9 | 15 | |
| 10 | 5 | |
| 11 | 24 | |
| 12 | 23 | |
| 13 | 14 | |
| 14 | 69 | |
| 15 | 0 | |
| 16 | 11 | |
| 17 | 3 | |
| 18 | 4 | |
| 19 | Adjuvant chemotherapy for osteosarcoma | 35 |
| 20 | 5 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.